Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indications for early cystectomy.

J P Stein1

  • 1Department of Urology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA 90089, USA.

Seminars in Urologic Oncology
|December 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complications of radical cystectomy.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2007
Same author

EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.

Oncogene·2005
Same author

The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression.

Cell death and differentiation·2003
Same author

Molecular prognostication in bladder cancer--a current perspective.

European journal of cancer (Oxford, England : 1990)·2003
Same author

Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.

BJU international·2003
Same author

Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer.

BJU international·2002
Same journal

The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.

Seminars in urologic oncology·2002
Same journal

Poor prognosis germ-cell tumors: An unresolved challenge.

Seminars in urologic oncology·2002
Same journal

Chemotherapy for good-risk germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?

Seminars in urologic oncology·2002
Same journal

Controversies in the management of testicular seminoma.

Seminars in urologic oncology·2002
See all related articles

Superficial bladder cancer treatment aims to prevent recurrence and progression. Radical cystectomy is a crucial option for high-risk patients, offering improved survival and prognostic insights.

Area of Science:

  • Urology
  • Oncology

Background:

  • Superficial bladder cancer management involves reducing recurrence and preventing progression.
  • Intravesical therapy is key, but some patients remain at risk of disease advancement.

Purpose of the Study:

  • To highlight the importance of vigilant management in superficial bladder cancer.
  • To emphasize the role of radical cystectomy in high-risk cases.

Main Methods:

  • Review of treatment goals and therapeutic options for superficial bladder cancer.
  • Discussion of indications for radical cystectomy versus conservative management.

Main Results:

  • Radical cystectomy offers excellent local recurrence prevention and survival rates in high-risk patients.

Related Experiment Videos

  • It provides prognostic information for adjuvant therapy decisions.
  • Advancements in reconstruction and nerve-sparing techniques minimize social impact.

    • Conclusions:

    • Active surveillance and timely consideration of radical cystectomy are vital for superficial bladder cancer.
    • Radical cystectomy is recommended for patients with high-risk factors to prevent lethal sequelae.